Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics.
Summary: Background: Childhood obesity is a major public health concern with limited treatment options. Objective: The aim of this study was to assess safety, tolerability, pharmacokinetics, and pharmacodynamics during short‐term treatment with liraglutide in children (7‐11 y) with obesity. Methods:...
| Publicado en: | Pediatric Obesity Vol. 14; no. 5 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Wiley-Blackwell
May2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |